CV Advisors’s Merck MRK Stock Holding History

CV Advisors’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.45M	Hold	10,000	–	–	0.24%	40
2026 Q2	$1.28M	Buy	+10,000	New	+$1.17M	0.24%	50

Other funds holding MRK

Smead Capital Management Phoenix, Arizona $4.71B AUM 32.07% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Quilter Plc London, United Kingdom $6.95B AUM 39.67% 1-Year Est. Return

Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

CV Advisors's MRK Position: Q3 2026 in Review

CV Advisors held its Merck (MRK) position steady in Q3 2026 at 10,000 shares worth $1.45M. The position accounts for 0.24% of the portfolio, ranked #40.

CV Advisors first reported a position in MRK in Q2 2026 and has held it in 2 quarters since. 1,277 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

CV Advisors held 10,000 shares of Merck worth $1.45M as of Q3 2026.
CV Advisors left its Merck share count unchanged in Q3 2026.
Merck made up 0.24% of CV Advisors's portfolio in Q3 2026, its #40 holding.
CV Advisors first reported a position in Merck in Q2 2026 and has held it in 2 quarters since.
1,277 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on CV Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.